U.S. REITS Stock News

NYSE:PRIM
NYSE:PRIMConstruction

Do Primoris (PRIM) Insiders See Limited Upside In Its Data Center And Renewables Pivot?

Primoris Services Corporation recently presented at the 2026 Cantor Global Technology & Industrial Growth Conference in New York, highlighting its role in building, maintaining, and upgrading utility, energy, and civil infrastructure. The presentation came as Primoris reported very large average backlog growth over the past two years, fast-compounding earnings, improved free cash flow margins, and stepped-up insider selling that has drawn closer scrutiny to management’s outlook and capital...
NYSE:SYF
NYSE:SYFConsumer Finance

Polaris Partnership Renewal Amid Soft Jobs Data Might Change The Case For Investing In Synchrony Financial (SYF)

In late February 2026, Synchrony announced it renewed its nearly 20-year financing partnership with Polaris Inc., continuing to offer customized promotional financing and loan options across Polaris’ U.S. dealer network and leveraging its PRISM credit decisioning system. At the same time, a weaker-than-expected February U.S. jobs report has raised concerns about rising credit risk for lenders like Synchrony Financial, adding a macroeconomic layer of uncertainty to the company’s...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

Arrowhead (ARWR): Do Strong Q1 Results and Plozasiran Hopes Outweigh Insider Selling Signals?

Arrowhead Pharmaceuticals recently delivered strong first quarter fiscal 2026 results that exceeded earnings and revenue expectations, while its Chief Medical Officer James C. Hamilton sold 10,000 shares on March 5, 2026 under a 10b5-1 trading plan, retaining direct ownership of 236,958 shares. Alongside the better-than-expected quarter, investors are closely watching Arrowhead’s Phase 3 plozasiran SHASTA3/4 trial, which analysts have identified as an important upcoming potential catalyst...
NYSE:CTRA
NYSE:CTRAOil and Gas

What Coterra Energy (CTRA)'s Strong 2025 Results and Higher Free Cash Flow Outlook Mean For Shareholders

Coterra Energy reported past fourth-quarter and full-year 2025 results on February 26, 2026, with higher natural gas, oil and NGL production, revenue of US$1,959 million for the quarter and US$7.65 billion for the year, and net income of US$368 million for the quarter and US$1.72 billion for the year. The company coupled these strong operating and financial results with 2026 production guidance, an affirmed US$0.22 quarterly dividend and a higher projected free cash flow profile, prompting...
NasdaqGS:PTON
NasdaqGS:PTONLeisure

Will Peloton’s (PTON) Profitability Jump and AI Push Reshape Its Core Fitness Platform Narrative

In recent results, Peloton Interactive reported a 39% year-over-year increase in Adjusted EBITDA to US$81 million, even as total revenue slipped 3%, and raised its FY2026 Adjusted EBITDA guidance on the back of growth in its commercial division and new offerings like the Peloton Cross Training Series and Peloton IQ. This combination of improved profitability and AI-driven product innovation underlines how Peloton is trying to deepen engagement and diversify beyond its core at-home bike user...
NasdaqGM:VERX
NasdaqGM:VERXSoftware

What Vertex (VERX)'s Insider Sale and CEO Transition Mean for Its Tax Tech Ambitions

On 9 March 2026, Item Second Irr. Trust FBO Kyle R. Westphal, a ten percent owner of Vertex, Inc., sold 10,000 shares of Class A common stock, while analysts issued mixed reactions to the company’s fourth-quarter 2025 results and CEO transition. The split between cautious analysts and a supportive view from Goldman Sachs, which highlighted Vertex’s global compliance and e-invoicing focus, underscores diverging opinions on how effectively the company can execute its long-term tax technology...
NasdaqGS:STNE
NasdaqGS:STNEDiversified Financial

StoneCo (STNE) Is Down 18.6% After Swinging To R$2.32B Profit In 2025 Has The Bull Case Changed?

In March 2026, StoneCo Ltd. reported fourth-quarter 2025 sales of R$3,725.3 million and net income of R$504.2 million, compared with sales of R$3,295.7 million and a net loss of R$2,921.8 million a year earlier, while full-year 2025 revenue reached R$14.15 billion and net income R$2.32 billion versus a net loss of R$1.52 billion in 2024. The shift from a very large prior-year loss to positive earnings per share of R$1.96 in the quarter and R$8.85 for 2025 highlights a substantial...
NasdaqGS:TXN
NasdaqGS:TXNSemiconductor

Is TI’s NVIDIA Robot Sensor Fusion Push Quietly Rewiring Its Industrial Automation Story for TXN?

In early March 2026, Texas Instruments announced a collaboration with NVIDIA to combine its real-time motor control, sensing, radar and power technologies with NVIDIA’s robotics compute and simulation platforms, aiming to accelerate safer real-world deployment of humanoid robots and showcasing a radar–camera sensor fusion demo at NVIDIA GTC in San Jose. A key innovation is TI’s mmWave radar-based sensor fusion with NVIDIA Jetson Thor, designed to deliver low-latency 3D perception and...
NYSE:CTRI
NYSE:CTRIConstruction

Assessing Centuri Holdings (CTRI) Valuation After Earnings Turnaround And 2026 Revenue Outlook

Centuri Holdings (CTRI) has just combined a turnaround earnings report with fresh 2026 revenue guidance, shifting from a full year net loss to net income and setting expectations for US$3.24b to US$3.54b in sales. See our latest analysis for Centuri Holdings. At a share price of US$30.01, Centuri’s recent earnings turnaround and 2026 revenue outlook sit against a 1-year total shareholder return of 78.10%, with a 90-day share price return of 16.82%. This suggests momentum has been building...
NYSE:VTR
NYSE:VTRHealth Care REITs

A Look At Ventas (VTR) Valuation After Recent Share Price Momentum

Ventas (VTR) continues to attract attention from income focused investors, with its S&P 500 real estate investment trust profile and exposure to senior housing and healthcare facilities across North America and the United Kingdom. See our latest analysis for Ventas. At a share price of $86.21, Ventas has posted an 11.48% year to date share price return, alongside a 31.29% total shareholder return over one year and a 112.30% total shareholder return over three years, which indicates momentum...
NYSE:CDRE
NYSE:CDREAerospace & Defense

How Slowing Revenue Expectations And A Recent Miss At Cadre Holdings (CDRE) Has Changed Its Investment Story

Cadre Holdings, Inc. has scheduled the release of its Q4 2025 results for after the market close on March 10, 2026, following a prior quarter in which revenue rose strongly year on year but fell short of analyst expectations. The upcoming report is drawing attention because analysts now expect a much slower revenue growth rate, sharpening focus on whether Cadre can sustain its recent expansion pace. We'll examine how the anticipated slowdown in revenue growth and recent estimate miss could...
NasdaqGS:EFSC
NasdaqGS:EFSCBanks

Assessing Enterprise Financial Services (EFSC) Valuation After Recent Short Term Share Price Weakness

Event context and recent share performance Enterprise Financial Services (EFSC) has drawn investor attention after recent trading, with the stock down about 1% over the past day, 6% over the past week, and roughly 10% over the past month. Those shorter term moves contrast with a small positive total return over the past year, as well as higher three and five year total returns. This has prompted some investors to reassess how the bank’s current pricing lines up with its fundamentals. See our...
NYSE:HAL
NYSE:HALEnergy Services

Should Halliburton’s (HAL) Earnings Beat and Pertamina Deal Shape Views on Its International Strategy?

Recently, Halliburton reported quarterly earnings and revenue that exceeded analyst expectations and signed a memorandum of understanding with PT Pertamina to deploy advanced well construction and stimulation technologies in Indonesia. This combination of earnings outperformance and a new Indonesian technology partnership underscores Halliburton’s push to build a broader, more geographically diverse service footprint. We’ll now examine how Halliburton’s Pertamina technology agreement could...
NYSE:WTS
NYSE:WTSMachinery

Does Watts Water Technologies' (WTS) Earnings Beat Reveal Durable Innovation Advantage Or Cyclical Outperformance?

Watts Water Technologies recently reported record fourth-quarter and full-year results, beating analyst expectations on revenue, EBITDA, operating income, and earnings per share, with management crediting its focus on water safety, conservation, and energy efficiency for the strong performance. By leading its water infrastructure peer group in both revenue growth and the size of its earnings beat despite broader industry challenges, Watts reinforced the competitive strength of its...
NasdaqGM:IRON
NasdaqGM:IRONBiotechs

A Look At Disc Medicine (IRON) Valuation After Recent Share Price Swings

Disc Medicine stock reacts after recent share price moves Disc Medicine (IRON) has drawn attention after recent share price swings, including a 5.0% gain over the past day, offset by declines over the past week, month, and past 3 months. See our latest analysis for Disc Medicine. The latest 1 day share price gain sits against weaker short term momentum, with the 30 day share price return of 19.43% decline and 90 day share price return of 29.97% decline contrasting with a 1 year total...
NasdaqGS:ERII
NasdaqGS:ERIIMachinery

A Look At Energy Recovery (ERII) Valuation After PX Q650 Desalination Launch

Why the PX Q650 launch matters for Energy Recovery (ERII) investors Energy Recovery (ERII) has drawn fresh attention after launching its PX Q650 Pressure Exchanger for desalination, combining higher flow capacity, very high stated efficiency, and extended warranties aimed at long-life plant operations. See our latest analysis for Energy Recovery. The PX Q650 launch comes on the heels of Energy Recovery’s recent earnings update. It arrives at a time when the stock has seen a 4.81% 1 day share...
NYSE:DT
NYSE:DTSoftware

Dynatrace (DT) Is Up 5.9% After EVP Share Purchase And AI Platform Spotlight – Has The Bull Case Changed?

In late February and early March 2026, Dynatrace drew attention as Executive Vice President Stephen McMahon bought 3,000 company shares for about US$107,250 and the firm highlighted its artificial intelligence-driven observability platform at Morgan Stanley’s Technology, Media & Telecom Conference in San Francisco. This combination of insider buying and a public focus on AI-enabled growth and raised profit guidance adds weight to Dynatrace’s existing growth and innovation story for...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Is New HIV Switch Data Reframing the Investment Case for Gilead Sciences’ Lenacapavir Platform (GILD)?

In February 2026, Gilead Sciences presented Phase 3 ARTISTRY-1 and ARTISTRY-2 data showing its investigational single-tablet bictegravir/lenacapavir HIV regimen maintained virologic suppression and was generally well tolerated, proving noninferior to both complex multi-tablet regimens and guideline-recommended single-tablet therapy through Week 48. This potential new once-daily option could simplify treatment for people living with HIV who are currently on complex regimens, reinforcing...
NasdaqGS:HTZ
NasdaqGS:HTZTransportation

How Investors May Respond To Hertz Global Holdings (HTZ) Narrowing Losses And Pershing Square’s Comeback Framing

Hertz Global Holdings, Inc. reported past fourth-quarter 2025 sales of US$2,028 million versus US$2,040 million a year earlier, with its quarterly net loss narrowing to US$194 million from US$479 million; full-year 2025 sales were US$8.50 billion versus US$9.05 billion, while the annual net loss improved to US$747 million from US$2.86 billion. Pershing Square’s 2025 commentary framed Hertz as an emerging comeback story, highlighting a refreshed fleet, higher utilization, and the company’s...
NYSE:BHVN
NYSE:BHVNBiotechs

Why Biohaven (BHVN) Is Down 13.5% After Narrower Losses And A New Share Shelf Registration

In March 2026, Biohaven Ltd. reported fourth-quarter and full-year 2025 results showing its net loss narrowed to US$145.56 million for the quarter and US$738.82 million for the year, alongside reduced basic loss per share. On the same day, Biohaven also filed a US$134.78 million shelf registration for nearly 11.7 million common shares tied to an employee stock ownership plan, highlighting ongoing efforts to access capital and incentivize staff. We will now examine how Biohaven’s narrower...
NasdaqGS:TROW
NasdaqGS:TROWCapital Markets

Will T. Rowe Price’s New UK Retirement Lead (TROW) Subtly Reframe Its Long‑Term Strategy?

T. Rowe Price has appointed Richard Parkin as head of UK retirement, effective 9 March 2026, bringing over 35 years of pensions and retirement experience from roles at BNY Investments, Fidelity International, and key industry bodies. Parkin’s remit to shape the firm’s UK retirement strategy across retail and institutional channels highlights T. Rowe Price’s focus on expanding retirement solutions alongside its growing assets under management and earnings base. Next, we’ll examine how...
NasdaqGM:IESC
NasdaqGM:IESCConstruction

Does IES Holdings (IESC) Director Share Sale Recast the Story on Governance and Capital Allocation?

IES Holdings recently held its 2026 Annual Stockholders Meeting, where all director nominees were elected and Ernst & Young was ratified as auditor, while Director Todd Cleveland sold 2,500 shares, trimming his personal stake. Together with ongoing attention on the Gulf Island acquisition, these governance developments are sharpening investor focus on how IES allocates capital and manages oversight. Next, we’ll examine how the director’s share sale and refreshed governance framework shape...
NasdaqGS:CHDN
NasdaqGS:CHDNHospitality

Does Churchill Downs (CHDN) Revenue-Earnings Split Recast Its Gaming-Led Growth Strategy?

Churchill Downs Incorporated has released its fourth-quarter and full-year 2025 results, showing higher revenue of US$665.9 million for the quarter and US$2.93 billion for the year, but lower net income of US$51.3 million and US$383 million respectively compared with the prior year. The company also opened Marshall Yards Racing & Gaming in Calvert City, Kentucky in February 2026, adding its eighth historical horse racing venue in the state and further tying gaming operations to purse funding...
NasdaqGS:ZVRA
NasdaqGS:ZVRAPharmaceuticals

Profit Swing, MIPLYFFA Uptake and New CFO Might Change The Case For Investing In Zevra Therapeutics (ZVRA)

Zevra Therapeutics, Inc. has reported its 2025 results, with full-year sales rising to US$106.47 million and net income reaching US$83.23 million, alongside fourth-quarter revenue of US$34.1 million and adjusted earnings of US$1.16 per share. Alongside these results, Zevra filed a US$22.86 million employee stock offering and named veteran finance executive Justin Renz as its new Chief Financial Officer, underscoring a focus on commercial scale-up and corporate development. We’ll now examine...